Jul 13, 2023 | Client Report, Cost Savings, Health care costs, Savings, Trend
Medical costs are expected to increase 7% in 2024, according to a new report from PricewaterhouseCoopers (PwC). This would match the largest single-year increase since the beginning of the pandemic. “The higher medical cost trend in 2024 reflects health plans’...
Jul 11, 2023 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Specialty Drugs, Transparency, Value
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
Jun 29, 2023 | Alternative Reimbursement Strategies, Cost Savings, Direct-to-Employer Contracting, Preferred provider organization (PPO), Savings
More self-funded employers are considering contracting directly with health systems and hospitals – and for good reason. Not only does direct-to-employer contracting offer better pricing than traditional PPOs, it offers advantages not found in other types of...
May 16, 2023 | Alternative Reimbursement Strategies, Announcements, Case Studies, Client Report, Client Services, Client Surveys, Communication, Compliance, Cost Plus Pricing, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, HealthJoy, Inflation, Kurt Harden, MedBen Rx, MedBen WellLiving, Member engagement, Mobile App, Online Services, Own Use, Pharmacy, Pharmacy Benefits Manager (PBM), Plan Design, Plan Language, Prescription, Reference-Based Pricing, Regulatory, Rx Costs, Savings, Self-funding, Specialty Drugs, Supreme Court, Wellness
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan. With health...
Apr 17, 2023 | biologics, Biosimilars, Brand Name Drugs, Cost Savings, Generic Drugs, Pharmacy, Prescription, Rx Costs, Savings
Much like generics are lower-cost equivalents of more expensive drugs, so too are biosimilars. But there’s a notable distinction between the two. Generics contain the exact same active ingredients as their brand-name counterparts and are usually synthesized from...
Apr 4, 2023 | Caroline Fraker, Carve-outs, Compliance, Cost Savings, Dialysis, MedBen University, Regulatory, Savings, Supreme Court
At this year’s MedBen University roundtables, Senior Vice President & CPO Caroline Fraker provided an eye-opening example of why the June 2022 United States Supreme Court decision in the matter of Marietta Memorial Hospital Employee Health Benefit Plan v....
